美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Propanc Biopharma, Inc.

2.27

-0.1600-6.58%

盤後：2.08-0.1901-8.37%19:59 EDT

成交量：186.82萬

成交額：382.38萬

市值：517.19萬

市盈率：-0.07

高：2.39

開：2.00

低：1.83

收：2.43

52周最高：270.25

52周最低：1.30

股本：227.84萬

流通股本：26.94萬

量比：0.05

換手率：693.57%

股息：- -

股息率：- -

每股收益(TTM):-32.4560

每股收益(LYR):-371.2241

淨資產收益率：-126.98%

總資產收益率：-62.31%

市淨率：0.53

市盈率(LYR):-0.01

資料載入中...

總覽公司新聞資訊公告

Propanc Biopharma, Inc.將在澳大利亞提交CTA，啓動針對30-40名晚期癌症患者的1B期研究

Propanc Biopharma公司計劃開展兩項II期研究，針對胰腺癌和卵巢癌各招募60名患者

Propanc Biopharma實施並股計劃，以維繫納斯達克上市地位並推進增長戰略

Propanc Biopharma公司提交文件，計劃由售股股東轉售最多1500萬股普通股——SEC備案披露

Propanc Biopharma與西班牙哈恩大學及格拉納達大學達成多年抗衰老與癌症研究合作

Propanc Biopharma, Inc. 優先推進PRP臨床開發，聚焦胰腺癌與卵巢癌治療

Propanc Biopharma公司PRP藥物I B期首次人體試驗定於2026年啓動；1億美元資金設施已就位

Propanc Biopharma, Inc. 公布PRP在臨床前胰腺癌模型中展示超過85%的腫瘤生長抑制效果

Propanc Biopharma與Fyonibio簽署服務協議，為1B期首次人體研究建立並驗證藥代動力學分析方法

Propanc Biopharma主力資產PRP在臨床前胰腺癌模型中顯示超過85%的腫瘤生長抑制率

幣圈日報 | Circle財報：總收入和儲備金收入增長64%達27億美元；哈佛、布朗等大學捐贈基金開始配置比特幣ETF

幣圈日報｜Meta擬下半年重啓穩定幣項目；香港穩定幣支付公司RedotPay考慮年內赴美IPO

幣圈日報｜Coinbase託管美國超八成比特幣、以太坊ETF資產；SEC專員提議支付型穩定幣2%資本扣減

幣圈日報 | CFTC主席：《數字資產市場透明度法案》預計獲國會通過；Tom Lee料2026年比特幣創歷史新高

幣圈日報 | Strategy再擲1億美元加碼比特幣，今年收益率23%；奈飛佈局加密貨幣主題電影

Propanc Biopharma提交招股説明書持股股東擬轉售200萬股

幣圈日報 | 「黑色19小時」：加密貨幣總市值縮水近千億；投行警告新一輪「加密寒冬」

幣圈日報 | 聖誕假期資金出逃，比特幣ETF淨流出近8億美元；加密財庫公司面臨出清壓力

聯儲局2026年第一季度展望：對比特幣和加密市場的潛在影響

2025年資產覆盤：為何比特幣會大幅跑輸黃金和美股？

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PPCB/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PPCB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","market":"US","secType":"STK","nameCN":"Propanc Biopharma, Inc.","latestPrice":2.27,"timestamp":1781294400000,"preClose":2.43,"halted":0,"volume":1868179,"hourTrading":{"tag":"盘后","latestPrice":2.0799,"preClose":2.27,"latestTime":"19:59 EDT","volume":47057,"amount":99017.093,"timestamp":1781308795466,"change":-0.1901,"changeRate":-0.083744,"amplitude":0.101322},"delay":0,"changeRate":-0.065843621399177,"floatShares":269356,"shares":2278372,"eps":-32.455997,"marketStatus":"休市中","change":-0.16,"latestTime":"06-12 16:00:00 EDT","open":2,"high":2.39,"low":1.83,"amount":3823792.513558,"amplitude":0.230453,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-32.455997,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1781510400000},"marketStatusCode":7,"adr":0,"listingDate":1743998400000,"exchange":"NASDAQ","adjPreClose":2.43,"preHourTrading":{"tag":"盘前","latestPrice":1.97,"preClose":2.43,"latestTime":"09:29 EDT","volume":324511,"amount":651854.5591657,"timestamp":1781270999047,"change":-0.46,"changeRate":-0.1893,"amplitude":0.156379},"postHourTrading":{"tag":"盘后","latestPrice":2.0799,"preClose":2.27,"latestTime":"19:59 EDT","volume":47057,"amount":99017.093,"timestamp":1781308795466,"change":-0.1901,"changeRate":-0.083744,"amplitude":0.101322},"volumeRatio":0.05345645261742947},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","floatShares":269356,"roa":"-62.31%","roe":"-126.98%","lyrEps":-371.224075,"volumeRatio":0.05345645261742947,"shares":2278372,"dividePrice":0,"high":2.39,"amplitude":0.230453,"preClose":2.43,"low":1.83,"week52Low":1.3,"pbRate":"0.53","week52High":270.25,"institutionHeld":0,"latestPrice":2.27,"eps":-32.455997,"divideRate":0,"volume":1868179,"delay":0,"ttmEps":-32.455997,"open":2,"prevYearClose":13.415,"prevWeekClose":1.45,"prevMonthClose":1.82,"prevQuarterClose":2.65,"fiveDayClose":1.45,"twentyDayClose":1.8275,"sixtyDayClose":2.9225},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPCB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-18","symbol":"PPCB","defaultRemindTime":1779111000000,"type":"split","dateTimestamp":1779076800000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2025-01-29","symbol":"PPCB","defaultRemindTime":1738161000000,"type":"split","dateTimestamp":1738126800000,"forFactor":60000,"toFactor":1,"ratio":60000},{"market":"US","date":"2023-05-23","symbol":"PPCB","defaultRemindTime":1684848600000,"type":"split","dateTimestamp":1684814400000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2020-11-19","symbol":"PPCB","defaultRemindTime":1605796200000,"type":"split","dateTimestamp":1605762000000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2019-06-24","symbol":"PPCB","type":"split","dateTimestamp":1561348800000,"forFactor":500,"toFactor":1,"ratio":500}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPCB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPCB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PPCB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PPCB","date":"2026-06-12","current":-0.069941,"percent":0.466667,"low":-1.336323,"twenty":-0.369488,"median":-0.091369,"eighty":-0.037013,"high":-0.023125,"avg":-0.191113,"sd":0.214463,"marketCap":2031540},"quantilePoints":[{"date":"2025-04-04","current":-0.050633,"twenty":-0.050633,"median":-0.050633,"eighty":-0.050633,"marketCap":84546},{"date":"2025-04-07","current":-0.048332,"twenty":-0.050633,"median":-0.050633,"eighty":-0.049713,"marketCap":80703},{"date":"2025-08-22","current":-0.938461,"twenty":-0.969897,"median":-0.655598,"eighty":-0.050633,"marketCap":51812834},{"date":"2025-08-29","current":-0.721182,"twenty":-0.884372,"median":-0.710781,"eighty":-0.050633,"marketCap":39816759},{"date":"2025-09-05","current":-0.457673,"twenty":-0.820575,"median":-0.688821,"eighty":-0.213449,"marketCap":25268328},{"date":"2025-09-12","current":-0.457673,"twenty":-0.778969,"median":-0.631034,"eighty":-0.41283,"marketCap":25268328},{"date":"2025-09-19","current":-0.506214,"twenty":-0.755854,"median":-0.517772,"eighty":-0.439644,"marketCap":27948302},{"date":"2025-09-26","current":-0.418378,"twenty":-0.712861,"median":-0.510837,"eighty":-0.435021,"marketCap":23098825},{"date":"2025-10-03","current":-0.399917,"twenty":-0.699454,"median":-0.498124,"eighty":-0.407301,"marketCap":23564414},{"date":"2025-10-10","current":-0.408611,"twenty":-0.69067,"median":-0.457673,"eighty":-0.403395,"marketCap":24076684},{"date":"2025-10-17","current":-0.343407,"twenty":-0.669984,"median":-0.449583,"eighty":-0.385572,"marketCap":20234660},{"date":"2025-10-24","current":-0.321672,"twenty":-0.645772,"median":-0.432247,"eighty":-0.369488,"marketCap":18953985},{"date":"2025-10-31","current":-0.269509,"twenty":-0.610693,"median":-0.4245,"eighty":-0.343407,"marketCap":15880366},{"date":"2025-11-07","current":-0.241906,"twenty":-0.556142,"median":-0.418378,"eighty":-0.313847,"marketCap":14253909},{"date":"2025-11-14","current":-0.169965,"twenty":-0.518234,"median":-0.404264,"eighty":-0.269509,"marketCap":10014876},{"date":"2025-11-21","current":-0.174454,"twenty":-0.514536,"median":-0.397743,"eighty":-0.234995,"marketCap":11061584},{"date":"2025-11-28","current":-0.188344,"twenty":-0.512687,"median":-0.384703,"eighty":-0.189884,"marketCap":11942288},{"date":"2025-12-05","current":-0.173885,"twenty":-0.509912,"median":-0.372748,"eighty":-0.182127,"marketCap":11025501},{"date":"2025-12-12","current":-0.170028,"twenty":-0.504827,"median":-0.356448,"eighty":-0.174606,"marketCap":10780935},{"date":"2025-12-19","current":-0.151754,"twenty":-0.498818,"median":-0.343407,"eighty":-0.171335,"marketCap":9622255},{"date":"2025-12-26","current":-0.139108,"twenty":-0.496968,"median":-0.326019,"eighty":-0.170682,"marketCap":8820401},{"date":"2026-01-02","current":-0.113099,"twenty":-0.476627,"median":-0.315152,"eighty":-0.168873,"marketCap":7171266},{"date":"2026-01-09","current":-0.101254,"twenty":-0.460447,"median":-0.284723,"eighty":-0.163023,"marketCap":6420182},{"date":"2026-01-16","current":-0.074044,"twenty":-0.457673,"median":-0.262988,"eighty":-0.151375,"marketCap":4694858},{"date":"2026-01-23","current":-0.056065,"twenty":-0.453513,"median":-0.243754,"eighty":-0.138341,"marketCap":3554888},{"date":"2026-01-30","current":-0.058573,"twenty":-0.449352,"median":-0.223866,"eighty":-0.121547,"marketCap":3713923},{"date":"2026-02-06","current":-0.042554,"twenty":-0.442879,"median":-0.192195,"eighty":-0.107345,"marketCap":2698240},{"date":"2026-02-13","current":-0.048688,"twenty":-0.435021,"median":-0.182701,"eighty":-0.093848,"marketCap":3087140},{"date":"2026-02-20","current":-0.048657,"twenty":-0.431486,"median":-0.176899,"eighty":-0.077306,"marketCap":3214676},{"date":"2026-02-27","current":-0.046857,"twenty":-0.428606,"median":-0.174834,"eighty":-0.060466,"marketCap":3095731},{"date":"2026-03-06","current":-0.040376,"twenty":-0.424799,"median":-0.173681,"eighty":-0.05647,"marketCap":2667530},{"date":"2026-03-13","current":-0.029045,"twenty":-0.422077,"median":-0.17085,"eighty":-0.050499,"marketCap":1918972},{"date":"2026-03-20","current":-0.028085,"twenty":-0.419765,"median":-0.170682,"eighty":-0.048484,"marketCap":1855535},{"date":"2026-03-27","current":-0.034166,"twenty":-0.417079,"median":-0.169454,"eighty":-0.047319,"marketCap":2257270},{"date":"2026-04-02","current":-0.035336,"twenty":-0.413827,"median":-0.167383,"eighty":-0.04606,"marketCap":2334602},{"date":"2026-04-10","current":-0.031762,"twenty":-0.406872,"median":-0.16427,"eighty":-0.043866,"marketCap":2098425},{"date":"2026-04-17","current":-0.033628,"twenty":-0.399911,"median":-0.155654,"eighty":-0.041322,"marketCap":2221738},{"date":"2026-04-24","current":-0.036697,"twenty":-0.399457,"median":-0.149858,"eighty":-0.040438,"marketCap":2424475},{"date":"2026-05-01","current":-0.032141,"twenty":-0.39557,"median":-0.138149,"eighty":-0.039889,"marketCap":2123505},{"date":"2026-05-08","current":-0.029421,"twenty":-0.386441,"median":-0.123469,"eighty":-0.037064,"marketCap":1943760},{"date":"2026-05-15","current":-0.023125,"twenty":-0.382964,"median":-0.117367,"eighty":-0.035899,"marketCap":1527837},{"date":"2026-05-22","current":-0.078772,"twenty":-0.376009,"median":-0.107725,"eighty":-0.036443,"marketCap":1446323},{"date":"2026-05-29","current":-0.077406,"twenty":-0.376009,"median":-0.101254,"eighty":-0.036697,"marketCap":1421242},{"date":"2026-06-05","current":-0.075584,"twenty":-0.369488,"median":-0.094421,"eighty":-0.037013,"marketCap":1387801},{"date":"2026-06-12","current":-0.110645,"twenty":-0.369488,"median":-0.091369,"eighty":-0.037013,"marketCap":2031540}],"updateTime":1781389305397},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPCB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1136433126","title":"Propanc Biopharma, Inc.將在澳大利亞提交CTA，啓動針對30-40名晚期癌症患者的1B期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1136433126","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136433126?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 20:46","pubTimestamp":1779281202,"startTime":"0","endTime":"0","summary":"Propanc Biopharma, Inc. 计划在澳大利亚提交临床试验申请，旨在启动一项涉及30至40名晚期癌症患者的1B期研究。这一举措标志着该公司在推进其新型癌症治疗方案的临床开发道路上迈出了关键一步。在澳大利亚提交CTA的决定，反映了公司利用该国高效监管框架和强大临床研究生态系统的战略考量。成功完成此阶段研究，有望为Propanc Biopharma, Inc.的核心产品管线带来重要的价值提升，并为其针对难治性癌症的开发策略提供关键支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPCB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186690041","title":"Propanc Biopharma公司計劃開展兩項II期研究，針對胰腺癌和卵巢癌各招募60名患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1186690041","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186690041?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 20:46","pubTimestamp":1779281199,"startTime":"0","endTime":"0","summary":"Propanc Biopharma公司宣布，将启动两项独立的II期临床研究，分别针对胰腺癌和卵巢癌患者。据悉，每项研究计划招募60名参与者，以评估其候选疗法的安全性与有效性。这一举措标志着该公司在推进其肿瘤治疗管线方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPCB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158942593","title":"Propanc Biopharma實施並股計劃，以維繫納斯達克上市地位並推進增長戰略","url":"https://stock-news.laohu8.com/highlight/detail?id=1158942593","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158942593?lang=zh_tw&edition=fundamental","pubTime":"2026-05-14 10:00","pubTimestamp":1778724015,"startTime":"0","endTime":"0","summary":"Propanc Biopharma公司已正式执行反向股票分割（并股）方案。此举旨在满足纳斯达克资本市场持续上市的最低股价要求，从而稳固其上市地位。同时，公司期望这一资本结构调整能为其既定的长期业务增长与拓展计划提供更坚实的基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PPCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118487671","title":"Propanc Biopharma公司提交文件，計劃由售股股東轉售最多1500萬股普通股——SEC備案披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1118487671","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118487671?lang=zh_tw&edition=fundamental","pubTime":"2026-04-11 05:33","pubTimestamp":1775856802,"startTime":"0","endTime":"0","summary":"Propanc Biopharma公司已向美国证券交易委员会提交相关文件，内容涉及一项由售股股东发起的普通股转售计划。根据备案信息，该计划拟转售的普通股数量最高可达1500万股。\n此次提交标志着售股股东可能将在公开市场进行大规模股份出售。相关细节已在SEC备案中列明，市场将密切关注此举对公司股权结构及二级市场股价的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PPCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193342077","title":"Propanc Biopharma與西班牙哈恩大學及格拉納達大學達成多年抗衰老與癌症研究合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1193342077","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193342077?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 20:46","pubTimestamp":1774356416,"startTime":"0","endTime":"0","summary":"Propanc Biopharma, Inc. (OTC PINK: PPCB) 已正式启动与西班牙哈恩大学及格拉纳达大学的长期研究合作。该合作项目聚焦于抗衰老机制与癌症治疗领域的前沿探索，旨在通过多学科交叉研究推动新型生物医药解决方案的开发。此次合作将整合双方在生物医药领域的科研优势，共同探索潜在的新型疗法，为应对全球老龄化挑战及癌症治疗提供新的科学依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PPCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169122345","title":"Propanc Biopharma, Inc. 優先推進PRP臨床開發，聚焦胰腺癌與卵巢癌治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1169122345","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169122345?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 21:07","pubTimestamp":1773320852,"startTime":"0","endTime":"0","summary":"Propanc Biopharma, Inc. 正全力推进其核心候选药物PRP的临床开发进程，并将胰腺癌与卵巢癌的治疗研究作为首要战略方向。公司致力于通过创新疗法应对这些高致死率癌症的临床挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PPCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142670016","title":"Propanc Biopharma公司PRP藥物I B期首次人體試驗定於2026年啓動；1億美元資金設施已就位","url":"https://stock-news.laohu8.com/highlight/detail?id=1142670016","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142670016?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 21:06","pubTimestamp":1773320789,"startTime":"0","endTime":"0","summary":"生物制药公司Propanc Biopharma Inc宣布，其主打候选药物PRP的I B期首次人体临床试验计划于2026年正式开展。该公司已确保一项高达1亿美元的资金支持，为临床试验的顺利推进提供了坚实的财务保障。\n此次I B期试验标志着PRP在研发进程中迈出关键一步，旨在评估该药物在人体中的安全性与初步疗效。充足的资金储备将助力公司高效执行临床开发计划，加速潜在疗法的上市进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PPCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167918509","title":"Propanc Biopharma, Inc. 公布PRP在臨床前胰腺癌模型中展示超過85%的腫瘤生長抑制效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1167918509","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167918509?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 21:06","pubTimestamp":1773320779,"startTime":"0","endTime":"0","summary":"Propanc Biopharma, Inc. 近期宣布，其研发的主要候选药物PRP在针对胰腺癌的临床前研究中取得了显著成果。数据显示，PRP能够有效抑制肿瘤生长，抑制率超过85%。这一积极结果凸显了PRP在治疗胰腺癌方面的巨大潜力，为后续的临床开发提供了强有力的科学依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PPCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192836728","title":"Propanc Biopharma與Fyonibio簽署服務協議，為1B期首次人體研究建立並驗證藥代動力學分析方法","url":"https://stock-news.laohu8.com/highlight/detail?id=1192836728","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192836728?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 20:45","pubTimestamp":1773146712,"startTime":"0","endTime":"0","summary":"Propanc Biopharma, Inc. 已正式与Fyonibio达成一项服务协议，核心目标是为其即将开展的1B期首次人体临床研究，建立并验证一套关键的药代动力学分析方法。该协议的签署标志着公司在推进其领先候选药物研发进程中迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPCB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170463595","title":"Propanc Biopharma主力資產PRP在臨床前胰腺癌模型中顯示超過85%的腫瘤生長抑制率","url":"https://stock-news.laohu8.com/highlight/detail?id=1170463595","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170463595?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 21:48","pubTimestamp":1772545721,"startTime":"0","endTime":"0","summary":"Propanc Biopharma, Inc. (OTC: PPCB) 宣布，其领先研发资产PRP在针对胰腺癌的临床前研究模型中，展现出超过85%的肿瘤生长抑制效果。这一积极数据进一步验证了PRP作为潜在抗癌疗法的有效性，特别是在治疗胰腺癌这一难治性癌症领域显示出巨大潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PPCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151214269","title":"幣圈日報 | Circle財報：總收入和儲備金收入增長64%達27億美元；哈佛、布朗等大學捐贈基金開始配置比特幣ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=1151214269","media":"老虎資訊","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151214269?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 11:13","pubTimestamp":1772075627,"startTime":"0","endTime":"0","summary":"Circle财报：总收入和储备金收入增长64%达27亿美元美股上市公司Circle发布2025财年业绩报告，其中披露截至2025年末的USDC流通量为753亿美元，增长72%；2025年第四季度USDC链上交易量为11.9万亿美元，增长247%；2025财年总收入和储备金收入为27亿美元，增长64%。哈佛、布朗等大学捐赠基金开始配置比特币ETF面对传统资产回报率预期下降，多家大学捐赠基金正在调整投资策略，开始配置加密货币 ETF。","market":"us","thumbnail":"https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"de82517d1c0c9896f40922dfef8b05eb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COIN","EZET","BTC.USD.CC","FBTC","00165","OP.USD.HKCC","EZBC","BTCM","CAN","MARA","COSM","SBET","IBIT","ETH.USD.CC","BTCS","RIOT","UNI.USD.CC","09618","ETH","EBON","SOS","ETHW","QETH","DOT.USD.CC","09923","FETH","RNDR.USD.HKCC","00863","CLSK","MSTR","BTM","BMNR","01328","02888","BITB","DYDX.USD.HKCC","ETHA","BRRR","02598","BTCW","NCTY","06060","PPCB","AAVE.USD.CC","ATOM.USD.HKCC","HODL","ICG","SNX.USD.CC","LDO.USD.HKCC","MATIC.USD.CC","ETHE","ARKB","BTCO","CETH","GBTC","MKR.USD.CC","09959","LTC.USD.CC","BTCT","AVAX.USD.CC","COMP.USD.CC","DEFI","LINK.USD.CC","USDT.USD.CC","BTBT","ETHV","BITO"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1177262629","title":"幣圈日報｜Meta擬下半年重啓穩定幣項目；香港穩定幣支付公司RedotPay考慮年內赴美IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1177262629","media":"老虎資訊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177262629?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 11:14","pubTimestamp":1771989265,"startTime":"0","endTime":"0","summary":"Meta计划2026年下半年重推稳定币项目据CoinDesk报道，知情人士透露，Facebook母公司Meta计划于2026年下半年重返稳定币领域，目前正寻求与第三方供应商合作以管理稳定币支付并实施新钱包功能。彭博社：香港稳定币支付公司RedotPay考虑最早于今年在美国IPO，融资额或超10亿美元据彭博社报道，总部位于香港的稳定币支付公司RedotPay正考虑在美国进行首次公开募股，潜在融资额超过10亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b6fc46e21f8550f5632d7b1743082cfa","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKB","DOT.USD.CC","EBON","QETH","BITB","ETHV","NCTY","USDT.USD.CC","09618","BTM","LDO.USD.HKCC","CLSK","FBTC","OP.USD.HKCC","RIOT","BMNR","MATIC.USD.CC","CETH","PPCB","BTC.USD.CC","09959","COMP.USD.CC","BTCT","SOS","BTCO","LTC.USD.CC","ATOM.USD.HKCC","DEFI","ETH.USD.CC","BITO","FETH","MARA","AAVE.USD.CC","CAN","ETH","02888","LINK.USD.CC","SNX.USD.CC","BTCW","01328","MSTR","IBIT","06060","EZET","COSM","GBTC","AVAX.USD.CC","BRRR","DYDX.USD.HKCC","MKR.USD.CC","RNDR.USD.HKCC","ICG","BTCM","ETHA","UNI.USD.CC","02598","09923","BTCS","COIN","00863","BTBT","SBET","ETHE","EZBC","HODL","ETHW","00165"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1114232543","title":"幣圈日報｜Coinbase託管美國超八成比特幣、以太坊ETF資產；SEC專員提議支付型穩定幣2%資本扣減","url":"https://stock-news.laohu8.com/highlight/detail?id=1114232543","media":"老虎資訊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114232543?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 11:20","pubTimestamp":1771903219,"startTime":"0","endTime":"0","summary":"Coinbase CEO：平台已托管超80%的美国比特币和以太坊ETF资产Coinbase首席执行官Brian Armstrong在X平台发文表示，Coinbase平台目前已托管超过80%的美国比特币与以太坊ETF资产，2025年录得ETF资金流入峰值达到310亿美元。Coinbase也是多家ETF发行方的指定托管合作伙伴，其中包括部分全球最大型金融机构及政府机构，并强调这是一项极其重要的责任。","market":"us","thumbnail":"https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"522dbccf05daeed01fd1bc280b91d6a4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06060","HODL","GBTC","PPCB","EBON","00165","09959","BTCO","BTCT","RIOT","AVAX.USD.CC","SOS","NCTY","09618","COSM","EZET","CETH","MARA","DOT.USD.CC","OP.USD.HKCC","00863","AAVE.USD.CC","IBIT","ETHW","MATIC.USD.CC","DEFI","BTM","DYDX.USD.HKCC","MSTR","USDT.USD.CC","BMNR","COIN","CLSK","BITO","BTC.USD.CC","FBTC","FETH","LDO.USD.HKCC","ARKB","BTCM","BTCW","SBET","BRRR","09923","ETHA","BTCS","BTBT","02598","01328","ETHV","MKR.USD.CC","UNI.USD.CC","LTC.USD.CC","COMP.USD.CC","ETH.USD.CC","ETH","ICG","BITB","02888","LINK.USD.CC","CAN","QETH","ATOM.USD.HKCC","SNX.USD.CC","RNDR.USD.HKCC","ETHE","EZBC"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1103979295","title":"幣圈日報 | CFTC主席：《數字資產市場透明度法案》預計獲國會通過；Tom Lee料2026年比特幣創歷史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1103979295","media":"老虎資訊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103979295?lang=zh_tw&edition=fundamental","pubTime":"2026-01-21 11:06","pubTimestamp":1768964810,"startTime":"0","endTime":"0","summary":"针对比特币，Tom Lee 表示仍预计比特币将在今年创下历史新高。Tom Lee 指出，能源、基础材料和黄金是 2026 年的优质配置资产，而 AI 和区块链行业将继续受益于增长红利。自 2023 年起，香港已向 11 家虚拟资产交易平台发牌，并预计于今年稍后发出稳定币牌照。","market":"us","thumbnail":"https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0d875668ba505ee0e28a4115d32b2d43","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETHW","LDO.USD.HKCC","BITO","01328","ATOM.USD.HKCC","OP.USD.HKCC","EZBC","DEFI","09618","UNI.USD.CC","DYDX.USD.HKCC","ETHV","FBTC","RNDR.USD.HKCC","BTBT","MKR.USD.CC","09923","LINK.USD.CC","RIOT","GBTC","IBIT","BMNR","COSM","00863","BRRR","02598","HODL","USDT.USD.CC","CLSK","ETH","ETHA","MARA","06060","QETH","AVAX.USD.CC","BTCS","BTM","EZET","DOT.USD.CC","MSTR","02888","BTCO","LTC.USD.CC","BTCM","SBET","09959","BITB","ETHE","BTC.USD.CC","MATIC.USD.CC","NCTY","CETH","PPCB","SOS","00165","CAN","ARKB","SNX.USD.CC","COMP.USD.CC","BTCW","COIN","BTCT","EBON","ICG","ETH.USD.CC","FETH","AAVE.USD.CC"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1185621009","title":"幣圈日報 | Strategy再擲1億美元加碼比特幣，今年收益率23%；奈飛佈局加密貨幣主題電影","url":"https://stock-news.laohu8.com/highlight/detail?id=1185621009","media":"老虎資訊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185621009?lang=zh_tw&edition=fundamental","pubTime":"2025-12-31 11:07","pubTimestamp":1767150438,"startTime":"0","endTime":"0","summary":"Strategy再斥资逾1亿美元买比特币，今年投资收益率达23.2%根据提交给美国证券交易委员会的文件，Strategy于12月22日至28日期间买入1229枚比特币，总金额约1.088亿美元，平均买入价格为每枚88,568美元。完成本次交易后，Strategy累计持有比特币数量提升至672,497枚，总投入成本约504.4亿美元，平均持仓成本为每枚74,997美元。文件显示，这笔加码使Strategy今年以来的比特币投资收益率达到23.2%。Strategy在上述期间出售663,450股普通股，净募集资金约1.088亿美元，并将全数资金用于购买比特币。","market":"us","thumbnail":"https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0719116048e8635291eb038da4a33aba","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01328","06060","BTCS","MKR.USD.CC","MATIC.USD.CC","GBTC","LINK.USD.CC","NCTY","CLSK","COIN","ETH","PPCB","09618","ETHV","BTBT","SBET","COSM","HODL","ARKB","ICG","ETHW","BTC.USD.CC","CETH","09959","USDT.USD.CC","02598","EZET","RIOT","SOS","FBTC","QETH","00165","BITO","ETHE","UNI.USD.CC","BTCT","IBIT","02888","ATOM.USD.HKCC","BTCW","DEFI","SNX.USD.CC","09923","BTCM","RNDR.USD.HKCC","BITB","ETHA","EZBC","DOT.USD.CC","00863","FETH","LDO.USD.HKCC","MSTR","CAN","DYDX.USD.HKCC","BMNR","BRRR","BTCO","COMP.USD.CC","ETH.USD.CC","LTC.USD.CC","OP.USD.HKCC","BTM","AVAX.USD.CC","MARA","EBON","AAVE.USD.CC"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1195378168","title":"Propanc Biopharma提交招股説明書 持股股東擬轉售200萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=1195378168","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195378168?lang=zh_tw&edition=fundamental","pubTime":"2025-12-30 19:08","pubTimestamp":1767092892,"startTime":"0","endTime":"0","summary":"Propanc Biopharma, Inc. 已向美国证券交易委员会（SEC）提交招股说明书，文件显示公司一名持股股东计划公开转售所持有的200万股普通股。此次股份转售属于股东个人行为，公司本身不会从此次交易中获得任何资金。该招股说明书为二级市场流通提供了必要法律依据，意味着现有股东可能通过公开市场减持其投资头寸。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PPCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133831706","title":"幣圈日報 | 「黑色19小時」：加密貨幣總市值縮水近千億；投行警告新一輪 「加密寒冬」","url":"https://stock-news.laohu8.com/highlight/detail?id=1133831706","media":"老虎資訊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133831706?lang=zh_tw&edition=fundamental","pubTime":"2025-12-30 10:47","pubTimestamp":1767062825,"startTime":"0","endTime":"0","summary":"加密货币总市值在过去19小时内缩水近1000亿美元据Cointelegraph，过去19小时内，加密货币总市值缩水近1000亿美元，从3.02万亿美元的峰值回落至2.93万亿美元。Waters质疑SEC放弃这些案件的理由以及如何防范市场欺诈，并指出一些公司在委员会正式投票前就宣布了终止消息。她还批评Atkins将SEC议程作为政府工具，通过员工声明而非正式规则执行政策转变。截至 2025 年 12 月 28 日，该公司持有总计 672,497 枚比特币，总投资约为 504.4 亿美元，平均购入价格为 74,997 美元每枚。","market":"us","thumbnail":"https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COIN","DYDX.USD.HKCC","00863","BTBT","MSTR","LINK.USD.CC","RNDR.USD.HKCC","RIOT","BTM","ETHW","BTCM","CETH","BTCT","CLSK","FETH","EBON","01328","USDT.USD.CC","02598","ETHE","09618","BRRR","COSM","OP.USD.HKCC","ATOM.USD.HKCC","DEFI","02888","LTC.USD.CC","ETH","SBET","SNX.USD.CC","BMNR","EZBC","AVAX.USD.CC","DOT.USD.CC","AAVE.USD.CC","IBIT","BTC.USD.CC","09959","FBTC","CAN","MARA","ARKB","NCTY","ETHV","ETH.USD.CC","BTCS","ETHA","EZET","LDO.USD.HKCC","HODL","00165","UNI.USD.CC","BITB","BTCW","COMP.USD.CC","GBTC","09923","BITO","06060","ICG","BTCO","MATIC.USD.CC","MKR.USD.CC","SOS","QETH","PPCB"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1130797705","title":"幣圈日報 | 聖誕假期資金出逃，比特幣ETF淨流出近8億美元；加密財庫公司面臨出清壓力","url":"https://stock-news.laohu8.com/highlight/detail?id=1130797705","media":"老虎資訊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130797705?lang=zh_tw&edition=fundamental","pubTime":"2025-12-29 11:13","pubTimestamp":1766978037,"startTime":"0","endTime":"0","summary":"圣诞假期机构退场，现货比特币ETF净流出7.82亿美元数据显示圣诞周期间，美国上市的现货比特币 ETF 出现大规模资金流出，累计净流出约 7.82 亿美元。其中，周五单日净流出达 2.76 亿美元，为假期内流出高峰。俄罗斯最大银行 Sberbank 发放首笔比特币抵押贷款俄罗斯最大银行 Sberbank 已向当地大型比特币矿企 Intelion Data 发放该国首笔以加密资产作为抵押的贷款。此次潜在收购将由未来资产集团旗下非金融子公司 Mirae Asset Consulting 主导，该公司已与 Korbit 主要股东签署谅解备忘录。","market":"us","thumbnail":"https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9712b6f035d7a01dae3855140d621802"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02888","DYDX.USD.HKCC","SNX.USD.CC","02598","BITO","BTCW","FBTC","BRRR","01328","ARKB","RNDR.USD.HKCC","DOT.USD.CC","USDT.USD.CC","00165","DEFI","ETH.USD.CC","09959","BMNR","BTCT","ICG","09618","06060","AAVE.USD.CC","COIN","FETH","BTBT","EZET","IBIT","NCTY","BTCM","CLSK","CAN","SOS","ETHA","ETHE","HODL","LDO.USD.HKCC","ATOM.USD.HKCC","ETHW","MKR.USD.CC","EZBC","EBON","MATIC.USD.CC","MSTR","PPCB","RIOT","BTC.USD.CC","GBTC","09923","ETH","AVAX.USD.CC","CETH","ETHV","QETH","BTCS","LTC.USD.CC","MARA","UNI.USD.CC","COSM","OP.USD.HKCC","BITB","LINK.USD.CC","COMP.USD.CC","BTM","00863","SBET","BTCO"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1115546116","title":"聯儲局2026年第一季度展望：對比特幣和加密市場的潛在影響","url":"https://stock-news.laohu8.com/highlight/detail?id=1115546116","media":"MarsBit","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115546116?lang=zh_tw&edition=fundamental","pubTime":"2025-12-26 10:42","pubTimestamp":1766716928,"startTime":"0","endTime":"0","summary":"如果美联储在 2026 年第一季度暂停降息且通胀压力持续，BTC 可能跌至 70,000 美元，ETH 可能跌至 2,400 美元。美国联邦储备委员会在 2025 年三次降息，主要集中在第四季度，因为失业率小幅上升，通胀显示出更明显的降温迹象。加密交易所 BTSE 的首席运营官 Jeff Mei 表示，如果美联储在整个 2026 年第一季度维持利率不变，BTC 可能跌至 70,000 美元，而 ETH 可能下探至 2,400 美元。","market":"us","thumbnail":"https://static.tigerbbs.com/d0771f6361d74a78ebbf8c2fdc55c6b7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/d0771f6361d74a78ebbf8c2fdc55c6b7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"aa1a41c297f5509553bc628cc4c9909b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://news.marsbit.co/20251226003102825626.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1758599025333","symbols":["ATOM.USD.HKCC","UNI.USD.CC","BTCM","COIN","DEFI","BTCT","BTM","OP.USD.HKCC","HODL","ETHW","IBIT","09923","SBET","CLSK","COSM","LINK.USD.CC","LDO.USD.HKCC","NCTY","02598","ETHE","PPCB","MSTR","USDT.USD.CC","06060","RNDR.USD.HKCC","FETH","ETHA","ETH","DYDX.USD.HKCC","RIOT","EBON","BMNR","SNX.USD.CC","EZBC","00165","BTBT","ETHV","BTCW","CETH","MKR.USD.CC","BTCO","BTCS","GBTC","DOT.USD.CC","BITO","01328","AAVE.USD.CC","00863","QETH","EZET","09959","02888","ETH.USD.CC","FBTC","09618","ICG","MARA","COMP.USD.CC","MATIC.USD.CC","LTC.USD.CC","CAN","BTC.USD.CC","BITB","SOS","ARKB","AVAX.USD.CC","BRRR"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1143793247","title":"2025年資產覆盤：為何比特幣會大幅跑輸黃金和美股？","url":"https://stock-news.laohu8.com/highlight/detail?id=1143793247","media":"深潮TechFlow","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143793247?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 09:40","pubTimestamp":1766626838,"startTime":"0","endTime":"0","summary":"多人在观察 2025 年比特币的表现时，会陷入单纯的价格对比，不理解它为何跑输了英伟达带领的美股，甚至跑输了传统避险资产黄金。虽然比特币被誉为数字黄金，但它目前依然高度依赖互联网基础设施和中心化的流动性通道。比特币现货 ETF 的普及，标志着这头野兽被正式驯化。归根结底，2025 年的比特币并非被证伪，而是被重新定价。","market":"us","thumbnail":"https://community-static.tradeup.com/news/1897c169bbf7d20b9b1311803ad71600","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/1897c169bbf7d20b9b1311803ad71600"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6072fa260e6ba419853b18c4f2bf8f68","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.techflowpost.com/article/detail_29665.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1592805329705","symbols":["ATOM.USD.HKCC","BMNR","OP.USD.HKCC","PPCB","06060","COSM","IBIT","BTM","DEFI","LINK.USD.CC","02598","GBTC","09618","ARKB","COIN","BTC.USD.CC","BTCW","NCTY","MARA","SNX.USD.CC","DYDX.USD.HKCC","HODL","02888","BITB","00863","EZET","AVAX.USD.CC","BTBT","MATIC.USD.CC","MSTR","BTCS","DOT.USD.CC","09923","SBET","FETH","BTCM","BITO","QETH","RIOT","BTCO","USDT.USD.CC","CLSK","SOS","ETH","LDO.USD.HKCC","ETH.USD.CC","UNI.USD.CC","ETHE","ICG","09959","EZBC","BTCT","ETHW","RNDR.USD.HKCC","EBON","01328","FBTC","00165","LTC.USD.CC","COMP.USD.CC","ETHA","MKR.USD.CC","CETH","ETHV","BRRR","CAN","AAVE.USD.CC"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}